Important safety updates for dabigatran etexilate

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1378, 2011-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dabigatran etexilate for venous thromboembolism: a safety evaluation

By Brown Richard Lip Gregory YH Gallego Pilar

Expert Opinion on Drug Safety, Vol. 13, Iss. 5, 2014-05 ,pp. : 639-647

Informa Healthcare

Access to resources Recommend Favorite

Dabigatran Etexilate

By Sanford Mark Plosker Greg L.

Drugs, Vol. 68, Iss. 12, 2008-01 ,pp. : 1699-1709

Adis International

Access to resources Recommend Favorite

Dabigatran etexilate: a winner vs warfarin in the UK context

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 641, 2011-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Alteplase/dabigatran etexilate: Ecchymosis: case report

Reactions Weekly, Vol. 1, Iss. 1436, 2013-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Dabigatran etexilate: VTE prophylaxis RE-MODELled

Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite